Search Results - "Wiezer, M.J."

Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed by Kuijpers, A.M, Hauptmann, M, Aalbers, A.G, Nienhuijs, S.W, de Hingh, I.H, Wiezer, M.J, van Ramshorst, B, van Ginkel, R.J, Havenga, K, Verwaal, V.J

“…Abstract Background CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now the preferred treatment of many peritoneal surface…”
Get full text

Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment by Braam, H.J, Boerma, D, Wiezer, M.J, van Ramshorst, B

“…Abstract Aim To compare the clinical outcome of a one-stage, primary tumour resection and hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, versus a…”
Get full text

50. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: Experimental or standard care? A survey of surgical oncologists and medical oncologists by Braam, H, Boerma, D, Wiezer, M.J, Van Ramshorst, B

Get full text

5. Synchronous liver metastasis and peritoneal carcinomatosis of colorectal cancer: A multicenter retrospective cohort study by Braam, H.J.W, Hoogwater, F.J.H, Van Oudheusden, T.R, Simkens, G.A, Boerma, D, Wiezer, M.J, Nienhuijs, S.W, De Hingh, I.H.J.T, Van Ramshorst, B

Get full text

430. Severe skeletal muscle depletion is associated with reoperation in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy by Van Vugt, J.L.A, Braam, H.J, Vestering, A, Bollen, T.L, Wiezer, M.J, Van Ramshorst, B, Boerma, D

Get full text

49. Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: Morbidity and survival analysis by Braam, H.J, Van Oudheusden, T.R, De Hingh, I.H.J.T, Nienhuijs, S.W, Boerma, D, Wiezer, M.J, Van Ramshorst, B

Get full text

47. Cytoreduction and hyperthermic intraperitoneal chemotherapy: A feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis by Van Oudheusden, T, Braam, H.J, Nienhuijs, S.W, Wiezer, M.J, Van Ramshorst, B, Luyer, M.D, Lemmens, V.E, De Hingh, I.H.J.T

Get full text

48. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: Risk factors, treatment options and prognosis by Van Oudheusden, T, Braam, H.J, Luyer, M.D, Wiezer, M.J, Van Ramshorst, B, Nienhuijs, S.W, De Hingh, I.H

Get full text

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival by Hagendoorn, J, van Lammeren, G, Boerma, D, van der Beek, E, Wiezer, M.J, van Ramshorst, B

“…Abstract Background Peritoneal carcinomatosis from colorectal origin carries a poor prognosis. Recent clinical studies show that cytoreductive surgery (CS)…”
Get full text

Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology by van Oudheusden, T.R., Braam, H.J., Nienhuijs, S.W., Wiezer, M.J., van Ramshorst, B., Luyer, P., de Hingh, I.H.

“…Background Signet ring cell cancer (SRCC) patients have a poor oncologic outcome. The aim of this study was to determine whether the potential drawbacks of…”
Get full text

Safety of bariatric surgery in the elderly: results from the Dutch National Registry by Bonouvrie, Daniëlle S., van de Pas, Kelly G.H., Janssen, Loes, Leclercq, Wouter K.G., Greve, Jan Willem M., van Dielen, François M.H., de Brauw, L.M., Castro, S.M.M. de, Damen, S.L., Jonker, F.H.W., Apers, J.A., Faneyte, I.F., Greve, J.W.M., Hazebroek, E.J., van’t Hof, G., Janssen, I.M.C., Jutte, E.H., Klaassen, R.A., Lagae, E.A.G.L., Langenhoff, B.S., Liem, R.S.L., Luijten, A.A.P.M., Nienhuijs, S.W., Schouten, R., Smeenk, R.M., Swank, D.J., Wiezer, M.J., Vening, W.

“…The increased human life expectancy and prevalence of obesity lead to more elderly people with obesity. As the popularity of bariatric surgery continues to…”
Get full text

Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study by Akpinar, Erman O., Liem, Ronald S.L., Nienhuijs, Simon W., Greve, Jan Willem M., Marang-van de Mheen, Perla J., de Brauw, L.M., de Castro, S.M.M., Damen, S.L., Demirkiran, A., Dunkelgrun, M., Faneyte, I.F., van ‘t Hof, G., Janssen, I.M.C., Klaassen, R.A., Lagae, E.A.G.L., Langenhoff, B.S., Luijten, A.A.P.M., Schouten, R., Smeenk, R.M., Swank, D.J., Wiezer, M.J., Vening, W.

“…Bariatric surgery among patients with obesity and type 2 diabetes (T2D) can induce complete remission. However, it remains unclear whether sleeve gastrectomy…”
Get full text

Risk factors for postoperative bleeding in bariatric surgery by Straatman, Jennifer, Verhaak, Tim, Demirkiran, Ahmet, Harlaar, Niels J., Cense, Huib A., Jonker, Frederik H.W., de Brauw, L.M., de Castro, S.M.M., Damen, S.L., Jonker, F., Dunkelgrün, M., Faneyte, I.F., Greve, J.W.M., Hazebroek, E.J., van ‘t Hof, G., Janssen, I.M.C., Jutte, E.H., Klaassen, R.A., Lagae, E.A.G.L., Langenhoff, B.S., Liem, R.S.L., Luijten, A.A.P.M., Nienhuijs, S.W., Schouten, R., Smeenk, R.M., Swank, D.J., Wiezer, M.J., Vening, W.

“…Postoperative bleeding remains a relatively common complication following bariatric surgery and may lead to morbidity and even mortality. To develop a…”
Get full text

Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology: Signet Ring Cell and Cytoreductive Surgery+HIPEC by van Oudheusden, T.R., Braam, H.J., Nienhuijs, S.W., Wiezer, M.J., van Ramshorst, B., Luyer, P., de Hingh, I.H.

Get full text

Does the Presence of Abscesses in Diverticular Disease Prelude Surgery? by van de Wall, B. J. M., Draaisma, W. A., Consten, E. C. J., van der Kaaij, R. T., Wiezer, M. J., Broeders, I. A. M. J.

“…Background Information on long-term outcome of patients treated conservatively for diverticular abscess is scarce. This study aims to compare diverticulitis…”
Get full text

Failed Sleeve Gastrectomy: Single Anastomosis Duodenoileal Bypass or Roux-en-Y Gastric Bypass? A Multicenter Cohort Study by Dijkhorst, Phillip J., Boerboom, Abel B., Janssen, Ignace M. C., Swank, Dingeman J., Wiezer, René M. J., Hazebroek, Eric J., Berends, Frits J., Aarts, Edo O.

“…Background Sleeve gastrectomy (SG) has become the most performed bariatric procedure to induce weight loss worldwide. Unfortunately, a significant portion of…”
Get full text

Single Anastomosis Duodenoileal Bypass or Roux-en-Y Gastric Bypass After Failed Sleeve Gastrectomy: Medium-Term Outcomes by Dijkhorst, Phillip J., Al Nawas, May, Heusschen, Laura, Hazebroek, Eric J., Swank, Dingeman J., Wiezer, René M.J., Aarts, Edo O.

“…Background Although the sleeve gastrectomy (SG) has good short-term results, it comes with a significant number of patients requiring revisional surgery…”
Get full text

Implications for IV posaconazole dosing in the era of obesity by Wasmann, Roeland E, Smit, Cornelis, van Donselaar, Marieke H, van Dongen, Eric P A, Wiezer, René M J, Verweij, Paul E, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…Abstract Background The prevalence of obesity has shown a dramatic increase over recent decades. Obesity is associated with underdosing of antimicrobial drugs…”
Get full text

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals by Wasmann, Roeland E, Smit, Cornelis, van Dongen, Eric P H, Wiezer, René M J, Adler-Moore, Jill, de Beer, Yvo M, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…In this prospective study, we examined the pharmacokinetics of 1 and 2 mg/kg liposomal amphotericin B in 16 morbidly obese individuals (104-177 kg). Body size…”
Get full text

Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults by Wasmann, Roeland E, Smit, Cornelis, ter Heine, Rob, Koele, Simon E, van Dongen, Eric P H, Wiezer, René M J, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…Abstract Objectives The rising pandemic of obesity means an increasing number of obese patients who require antimicrobial therapy for serious infections…”
Get full text